Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jennifer M. Rubatt"'
Autor:
Alec Vaezi, Lin Wang, Nikhil R. Bhagwat, Brian L. Hood, Thomas P. Conrads, Gerold Bepler, Agnes Malysa, Wei Chen, Carolyn Kemp, Laura J. Niedernhofer, Jennifer M. Rubatt
Publikováno v:
Cancer. 120:1898-1907
BACKGROUND The determination of in situ protein levels of ERCC1 with the 8F1 monoclonal antibody is prognostic of survival in patients with non-small cell lung cancer (NSCLC). The authors previously demonstrated that 8F1 recognizes a second nuclear a
Autor:
Angeles Alvarez Secord, Kathleen M. Darcy, Jennifer M. Rubatt, Andrew Berchuck, Lisa A. Grace, Laura J. Havrilesky, Alan D. Hutson, Sarah M. Bean
Publikováno v:
Gynecologic Oncology. 112:469-474
The aims of this study were to examine prognostic significance of microvessel density (MVD) in previously-untreated, advanced epithelial ovarian cancer (EOC) and explore associations between MVD and factors that affect angiogenesis.MVD was determined
Autor:
Andrew Berchuck, Timothy J. Fischer, Jennifer M. Rubatt, Robert L. Cheek, Clark M. Whitehead, Qin He, John W. Groelke, Douglas P. Malinowski, Laura J. Havrilesky
Publikováno v:
Gynecologic Oncology. 110:374-382
Objective To determine the utility of novel combinations of biomarkers, using both a one-step and two-step assay format, to distinguish serum of early ovarian cancer patients from that of healthy controls and to discern the utility of these biomarker
Publikováno v:
Gynecologic Oncology. 99:472-476
Background. Conservative treatment with progestins is a reasonable treatment option for endometrial complex atypical hyperplasia and, in the experimental setting, for some women with grade 1 endometrial endometrioid adenocarcinoma. The risk of progre
Autor:
Angeles Alvarez Secord, Andrew Berchuck, Wei Chen, Jennifer M. Rubatt, William John Soper, Marcus Q. Bernardini, Brittany A. Davidson, Sharareh Siamakpour-Reihani, Kouros Owzar, David L. Corcoran, Deanna K. Teoh, Lisa A. Grace, Susan K. Murphy
Publikováno v:
Frontiers in Oncology, Vol 4 (2014)
Frontiers in Oncology
Frontiers in Oncology
Objectives: Underlying mechanisms regulating angiogenesis in ovarian cancer have not been completely elucidated. Evidence suggests that the TP53 tumor suppressor pathway and tumor microenvironment play integral roles. We utilized microarray technolog
Autor:
Michael J. Birrer, Laura J. Niedernhofer, Deborah K. Armstrong, Chunqiao Tian, Jennifer M. Rubatt, Kathleen M. Darcy, Julie A. DeLoia, Thomas C. Krivak, Franco M. Muggia, Michael A. Bookman, Rajiv Dhir
Excision repair cross-complementation group 1 (ERCC1) is required for the repair of platinum-induced DNA damage. This study sought to assess the prognostic value of ERCC1 expression, measured by immunohistochemistry (IHC) using a highly specific anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2908b6940cc872ed1c4c760a9ffb159
https://europepmc.org/articles/PMC3490188/
https://europepmc.org/articles/PMC3490188/
Autor:
Jennifer M. Rubatt, Lisa A. Grace, Andrew Berchuck, Mark D. Starr, Susan K. Murphy, Tina A. Ayeni, William T. Barry, David J. Adams, Angeles Alvarez Secord, Deanna Teoh
Purpose To explore the activity of dasatinib alone and in combination with paclitaxel and carboplatin in ovarian cancer cells and to determine if dasatinib activity can be predicted based on evaluation of the SRC pathway. Experimental design Microarr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d007d29d2af63d0ed4262bf0abfb1c9
https://europepmc.org/articles/PMC3062679/
https://europepmc.org/articles/PMC3062679/